Erektil dysfunktion og metabolisk syndrom

Klara Kvorning Ternov; Peter Busch Østergren; Mikkel Fode; Lars Lund

Erektil dysfunktion og metabolisk syndrom

Klara Kvorning Ternov, Peter Busch Østergren, Mikkel Fode, Lars Lund

Publikation: Bidrag til tidsskrift › Review › peer review

18 Downloads (Pure)

Abstract

This review covers erectile dysfunction (ED) in men with metabolic syndrome. Men suffering from metabolic syndrome, and all its components, are at increased risk of ED. Men with ED should be metabolically screened with BMI, waist circumference, blood pressure, HbA1c and lipids. Components of the metabolic syndrome should be well-controlled as first step in treating ED using lifestyle changes and pharmaceutical therapies. Symptomatic treatments include phosphodiesterase type 5 inhibitors, penile injections, intraurethral medication, vacuum pumps and penile implants.

Bidragets oversatte titel	Erectile dysfunction and metabolic syndrome
Originalsprog	Dansk
Artikelnummer	V03220227
Tidsskrift	Ugeskrift for Laeger
Vol/bind	184
Udgave nummer	42
Antal sider	8
ISSN	0041-5782
Status	Udgivet - 17 okt. 2022

Emneord

Male
Humans
Erectile Dysfunction/drug therapy
Metabolic Syndrome/complications
Penile Prosthesis/adverse effects
Phosphodiesterase 5 Inhibitors/therapeutic use

Adgang til dokumentet

FulltextForlagets udgivne version, 306 KBLicens: CC BY-NC-ND

https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2022-10/v03220227_web.pdfLicens: CC BY-NC-ND

Citationsformater

@article{85a084939abf448386a17e8be3405ef8,

title = "Erektil dysfunktion og metabolisk syndrom",

abstract = "This review covers erectile dysfunction (ED) in men with metabolic syndrome. Men suffering from metabolic syndrome, and all its components, are at increased risk of ED. Men with ED should be metabolically screened with BMI, waist circumference, blood pressure, HbA1c and lipids. Components of the metabolic syndrome should be well-controlled as first step in treating ED using lifestyle changes and pharmaceutical therapies. Symptomatic treatments include phosphodiesterase type 5 inhibitors, penile injections, intraurethral medication, vacuum pumps and penile implants.",

keywords = "Male, Humans, Erectile Dysfunction/drug therapy, Metabolic Syndrome/complications, Penile Prosthesis/adverse effects, Phosphodiesterase 5 Inhibitors/therapeutic use",

author = "Ternov, {Klara Kvorning} and {\O}stergren, {Peter Busch} and Mikkel Fode and Lars Lund",

year = "2022",

month = oct,

day = "17",

language = "Dansk",

volume = "184",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "42",

}

TY - JOUR

T1 - Erektil dysfunktion og metabolisk syndrom

AU - Ternov, Klara Kvorning

AU - Østergren, Peter Busch

AU - Fode, Mikkel

AU - Lund, Lars

PY - 2022/10/17

Y1 - 2022/10/17

N2 - This review covers erectile dysfunction (ED) in men with metabolic syndrome. Men suffering from metabolic syndrome, and all its components, are at increased risk of ED. Men with ED should be metabolically screened with BMI, waist circumference, blood pressure, HbA1c and lipids. Components of the metabolic syndrome should be well-controlled as first step in treating ED using lifestyle changes and pharmaceutical therapies. Symptomatic treatments include phosphodiesterase type 5 inhibitors, penile injections, intraurethral medication, vacuum pumps and penile implants.

AB - This review covers erectile dysfunction (ED) in men with metabolic syndrome. Men suffering from metabolic syndrome, and all its components, are at increased risk of ED. Men with ED should be metabolically screened with BMI, waist circumference, blood pressure, HbA1c and lipids. Components of the metabolic syndrome should be well-controlled as first step in treating ED using lifestyle changes and pharmaceutical therapies. Symptomatic treatments include phosphodiesterase type 5 inhibitors, penile injections, intraurethral medication, vacuum pumps and penile implants.

KW - Male

KW - Humans

KW - Erectile Dysfunction/drug therapy

KW - Metabolic Syndrome/complications

KW - Penile Prosthesis/adverse effects

KW - Phosphodiesterase 5 Inhibitors/therapeutic use

M3 - Review

C2 - 36305253

SN - 0041-5782

VL - 184

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 42

M1 - V03220227

ER -